LncRNA SNHG8 induces ovarian carcinoma cells cellular process and stemness through Wnt/β-catenin pathway.

Cancer Biomarkers : Section a of Disease Markers
Wei MiaoHui Zhang

Abstract

Ovarian carcinoma ranks fifth in the leading causes of cancer-relevant deaths among the female, with the highest fatality rate in all gynecological malignant tumors and the rising incidence worldwide. Mounting evidence has unveiled that lncRNAs are implicated in the tumorigenesis and cancer development. Several studies have proven the carcinogenic role of SNHG8 in various malignancies, but the physiological functions of SNHG8 in ovarian carcinoma need more detailed explanations. The present study certified that inhibition of SNHG8 executed suppressive activities in ovarian carcinoma by obstructing cell proliferation, migration, EMT process and stemness as well as driving cell apoptosis. Moreover, SNHG8 bound with CAPRIN1 and positively modulated the expression of CAPRIN1. Further experiments manifested that CTNNB1 and Axin1 displayed a binding affinity with CAPRIN1. Knockdown of CAPRIN1 promoted the mRNA degradation of CTNNB1 and Axin1. Finally, we corroborated that CTNNB1 (or Axin1) ectopic expression or activation of Wnt/β-catenin pathway abrogated the effects of SNHG8 downregulation on the cellular process of ovarian carcinoma cells. To summarize, SNHG8 acted as an oncogene in ovarian carcinoma via targeting Wnt/β-catenin pa...Continue Reading

References

Aug 22, 2002·Nature Reviews. Cancer·Jean Paul Thiery
Apr 30, 2003·Nature·Tannishtha ReyaIrving L Weissman
Apr 15, 2005·Nature·Tannishtha Reya, Hans Clevers
Apr 29, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Nobuyuki ShiinaMakio Tokunaga
Jan 16, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles N LandenAnil K Sood
Jul 22, 2009·Developmental Cell·Bryan T MacDonaldXi He
Nov 17, 2010·Genes & Development·Luca GrumolatoStuart A Aaronson
May 12, 2011·International Reviews of Immunology·Leonardo MirandolaMaurizio Chiriva-Internati
Feb 18, 2012·Nature·Mitchell Guttman, John L Rinn
Sep 8, 2012·Nature·Sarah DjebaliThomas R Gingeras
Dec 5, 2012·Cold Spring Harbor Perspectives in Biology·Xinhong Lim, Roel Nusse
Jan 30, 2013·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Man-Tang QiuLin Xu
Aug 21, 2013·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Bo GongLei Zhang
Jan 9, 2014·CA: a Cancer Journal for Clinicians·Rebecca SiegelAhmedin Jemal
Jan 17, 2017·Medical Science Monitor : International Medical Journal of Experimental and Clinical Research·Chongyuan ZhangPing Hu
Dec 13, 2017·Bioscience Reports·Jie LiZeshan You
Dec 12, 2018·Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology·Jiayong DongZhiren Fu

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Migration in Cancer and Metastasis

Migration of cancer cells into surrounding tissue and the vasculature is an initial step in tumor metastasis. Discover the latest research on cell migration in cancer and metastasis here.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Cell Migration

Cell migration is involved in a variety of physiological and pathological processes such as embryonic development, cancer metastasis, blood vessel formation and remoulding, tissue regeneration, immune surveillance and inflammation. Here is the latest research.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.